Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 28% ± 5% | |
endothelial cell of lymphatic vessel | 6 studies | 32% ± 8% | |
adipocyte | 5 studies | 22% ± 4% | |
type I pneumocyte | 5 studies | 24% ± 8% | |
fibroblast | 4 studies | 28% ± 4% | |
endothelial cell of vascular tree | 3 studies | 27% ± 11% | |
club cell | 3 studies | 27% ± 9% | |
alveolar macrophage | 3 studies | 22% ± 7% | |
macrophage | 3 studies | 17% ± 1% | |
type II pneumocyte | 3 studies | 22% ± 4% | |
astrocyte | 3 studies | 23% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1016.11 | 964 / 966 | 98% | 6.12 | 517 / 527 |
esophagus | 100% | 1132.86 | 1444 / 1445 | 98% | 7.23 | 179 / 183 |
lung | 100% | 2108.75 | 578 / 578 | 98% | 8.36 | 1127 / 1155 |
skin | 100% | 1016.17 | 1808 / 1809 | 95% | 5.71 | 449 / 472 |
breast | 100% | 2001.67 | 459 / 459 | 95% | 5.65 | 1062 / 1118 |
thymus | 100% | 2492.04 | 652 / 653 | 93% | 28.80 | 564 / 605 |
bladder | 100% | 1372.67 | 21 / 21 | 93% | 5.71 | 468 / 504 |
uterus | 100% | 1354.99 | 170 / 170 | 91% | 4.87 | 416 / 459 |
kidney | 100% | 737.90 | 89 / 89 | 90% | 5.19 | 809 / 901 |
ovary | 100% | 2107.79 | 180 / 180 | 81% | 3.47 | 349 / 430 |
stomach | 81% | 789.26 | 290 / 359 | 97% | 6.60 | 277 / 286 |
adrenal gland | 96% | 449.38 | 247 / 258 | 68% | 3.28 | 156 / 230 |
prostate | 99% | 862.64 | 243 / 245 | 61% | 2.02 | 306 / 502 |
pancreas | 46% | 160.48 | 150 / 328 | 95% | 5.99 | 169 / 178 |
brain | 39% | 131.14 | 1032 / 2642 | 67% | 2.75 | 475 / 705 |
adipose | 100% | 2158.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1875.44 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 984.95 | 857 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 938.79 | 1328 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 4.07 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 79% | 2.88 | 63 / 80 |
muscle | 77% | 316.99 | 621 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 4.32 | 22 / 29 |
peripheral blood | 67% | 405.63 | 625 / 929 | 0% | 0 | 0 / 0 |
liver | 26% | 92.93 | 58 / 226 | 29% | 1.04 | 119 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007254 | Biological process | JNK cascade |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0098792 | Biological process | xenophagy |
GO_0070427 | Biological process | nucleotide-binding oligomerization domain containing 1 signaling pathway |
GO_0002221 | Biological process | pattern recognition receptor signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0032874 | Biological process | positive regulation of stress-activated MAPK cascade |
GO_0016045 | Biological process | detection of bacterium |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0045087 | Biological process | innate immune response |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0007165 | Biological process | signal transduction |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0002606 | Biological process | positive regulation of dendritic cell antigen processing and presentation |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_1904417 | Biological process | positive regulation of xenophagy |
GO_0051403 | Biological process | stress-activated MAPK cascade |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0042742 | Biological process | defense response to bacterium |
GO_0060907 | Biological process | positive regulation of macrophage cytokine production |
GO_0009595 | Biological process | detection of biotic stimulus |
GO_0006915 | Biological process | apoptotic process |
GO_0071225 | Biological process | cellular response to muramyl dipeptide |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0006952 | Biological process | defense response |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005829 | Cellular component | cytosol |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0005737 | Cellular component | cytoplasm |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0050700 | Molecular function | CARD domain binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0042834 | Molecular function | peptidoglycan binding |
GO_0038187 | Molecular function | pattern recognition receptor activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO_0042802 | Molecular function | identical protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0043130 | Molecular function | ubiquitin binding |
Gene name | NOD1 |
Protein name | Nucleotide-binding oligomerization domain-containing protein 1 (hNod1) (Caspase recruitment domain-containing protein 4) Nucleotide-binding oligomerization domain containing 1 isoform 2 (Nucleotide-binding oligomerization domain containing 1 isoform 3) (Nucleotide-binding oligomerization domain containing 1 isoform 4) Nucleotide binding oligomerization domain containing 1 Caspase recruitment domain family, member 4 (Nucleotide-binding oligomerization domain containing 1 isoform 1) Caspase recruitment domain family, member 4, isoform CRA_c (Nucleotide binding oligomerization domain containing 1) |
Synonyms | hCG_39138 CARD4 tcag7.679 |
Description | FUNCTION: Pattern recognition receptor (PRR) that detects bacterial peptidoglycan fragments and other danger signals and thus participates in both innate and adaptive immune responses . Specifically recognizes and binds gamma-D-glutamyl-meso-diaminopimelic acid (iE-DAP), a dipeptide present in peptidoglycan of Gram-negative bacteria . Preferentially binds iE-DAP in tripeptide-containing muropeptides (MurNAc-TriDAP or TriDAP) . Ligand binding triggers oligomerization that facilitates the binding and subsequent activation of the proximal adapter receptor-interacting RIPK2 . Following recruitment, RIPK2 undergoes 'Met-1'- (linear) and 'Lys-63'-linked polyubiquitination by E3 ubiquitin-protein ligases XIAP, BIRC2, BIRC3 and the LUBAC complex, becoming a scaffolding protein for downstream effectors, triggering activation of the NF-kappa-B and MAP kinases signaling . This in turn leads to the transcriptional activation of hundreds of genes involved in immune response . Also acts as a regulator of antiviral response elicited by dsRNA and the expression of RLR pathway members by targeting IFIH1 and TRAF3 to modulate the formation of IFIH1-MAVS and TRAF3-MAVS complexes leading to increased transcription of type I IFNs . Also acts as a regulator of autophagy via its interaction with ATG16L1, possibly by recruiting ATG16L1 at the site of bacterial entry (By similarity). Besides recognizing pathogens, also involved in the endoplasmic reticulum stress response: acts by sensing and binding to the cytosolic metabolite sphingosine-1-phosphate generated in response to endoplasmic reticulum stress, initiating an inflammation process that leads to activation of the NF-kappa-B and MAP kinases signaling . In addition, plays a role in insulin trafficking in beta cells in a cell-autonomous manner (By similarity). Mechanistically, upon recognizing cognate ligands, NOD1 and RIPK2 localize to insulin vesicles where they recruit RAB1A to direct insulin trafficking through the cytoplasm (By similarity). .; FUNCTION: [Isoform 3]: In contrast to isoform 1, does not efficiently recognize and bind gamma-D-glutamyl-meso-diaminopimelic acid (iE-DAP) ligand. . |
Accessions | ENST00000434755.5 A0A0S2Z4W5 ENST00000419601.1 ENST00000419799.5 A0A024RA73 ENST00000222823.9 [Q9Y239-1] C9J8X8 A0A1B0GX71 Q9Y239 ENST00000411552.5 G3XAL1 ENST00000413433.5 |